Triglav Skladi D.O.O. Invests $380,000 in Agilent Technologies, Inc. (NYSE:A)

Triglav Skladi D.O.O. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,830 shares of the medical research company's stock, valued at approximately $380,000.

Several other institutional investors also recently bought and sold shares of the stock. Sienna Gestion raised its position in shares of Agilent Technologies by 29.8% in the 4th quarter. Sienna Gestion now owns 78,445 shares of the medical research company's stock worth $10,537,000 after acquiring an additional 17,991 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Agilent Technologies by 8.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company's stock valued at $4,554,000 after purchasing an additional 2,664 shares during the last quarter. Prudential PLC boosted its stake in Agilent Technologies by 16.0% during the 4th quarter. Prudential PLC now owns 73,273 shares of the medical research company's stock valued at $9,843,000 after purchasing an additional 10,128 shares during the last quarter. Commonwealth Equity Services LLC boosted its stake in Agilent Technologies by 9.8% during the 4th quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock valued at $5,892,000 after purchasing an additional 3,915 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Agilent Technologies by 16.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company's stock worth $6,621,000 after buying an additional 6,802 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on A shares. TD Cowen raised their price target on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Barclays dropped their price target on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Robert W. Baird dropped their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday. Wells Fargo & Company dropped their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Finally, Jefferies Financial Group lowered their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $141.42.

Insider Buying and Selling at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

NYSE:A traded up $0.82 on Thursday, reaching $109.73. 2,379,844 shares of the company's stock traded hands, compared to its average volume of 1,922,250. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a 50-day simple moving average of $109.98 and a 200-day simple moving average of $127.76. The firm has a market cap of $31.28 billion, a PE ratio of 25.23, a P/E/G ratio of 3.20 and a beta of 1.27. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.90%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.